tradmap

MIR Mirion Technologies, Inc.

$18.66 +1.69%

Data as of close

Healthcare · Measuring & Controlling Devices, Nec

Mirion Technologies, Inc. (MIR) is a healthcare company in the Measuring & Controlling Devices, Nec industry, with a market capitalization of $4.5 billion. Shares last traded at $18.66, 37.3% below their 52-week high. Over the past year the stock is down 35.7%. MIR trades at a price-to-earnings ratio of 154.26, above the Measuring & Controlling Devices, Nec median of 40.70. Net profit margin is 2.7%, above the peer median of -1.6%. Revenue grew 7.5% year over year.

Market Cap
$4.5B
Shares Out
239.7M
EPS (TTM)
$0.12
P/E (TTM)*
154.26
P/S Ratio
4.14
P/B Ratio
2.50
Dividend / Share
—
Dividend Yield
—
52-Week High
$29.76
52-Week Low
$14.04
Volume (venue)
368,804
Avg Vol (3m, venue)
270,258.778

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+25.11%
1M
+27.81%
3M
+15.19%
6M
-7.51%
YTD
-20.27%
1Y
-35.70%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
69.93
SMA (50)
$15.75
SMA (200)
$18.26
Price vs SMA50
+18.45%
Price vs SMA200
+2.21%
ATR (14)
$0.87

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$1.1B
Net Income
$29M
Gross Margin
48.1%
Operating Margin
6.0%
Net Margin
2.7%
Return on Equity
1.6%
Return on Assets
0.8%
Current Ratio
3.02
Debt / Equity
0.25
Revenue Growth (YoY)
+7.5%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-09-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q3 2026 $0.03 2026-10-28
Q2 2026 $0.03 2026-07-29
Q1 2026 -$0.01 2026-04-29
Q4 2025 (derived) $0.07 2026-02-19
FY 2025 $0.11 2026-02-19
Q3 2025 $0.01 2025-10-29

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Measuring & Controlling Devices, Nec peers

MIR vs 10 industry peers (Measuring & Controlling Devices, Nec), by market cap. Data as of close

P/E vs peers
154.26 / 40.70 med
+279% premium
P/S vs peers
4.14 / 4.14 med
+0% premium
Net margin vs peers
2.7% / -1.6% med
above median
1–10 of 10
TMOThermo Fisher Scientific$253.0B35.775.3414.9%-2.03%
ROKRockwell Automation$48.9B40.705.4513.4%+0.87%
TRMBTrimble Inc.$15.4B—4.06-2.8%+1.42%
ONTOOnto Innovation$9.4B—9.34-0.4%-5.02%
MIRMirion Technologies, Inc.$4.5B154.264.142.7%+1.69%
QSIQuantum-Si Inc$274M—170.47—-13.79%
OWLTOwlet, Inc.$126M—1.10-7.8%+6.28%
GEOSGEOSPACE TECHNOLOGIES CORP$53M—0.58-43.1%-7.01%
BCHTBirchtech Corp.$29M—1.49-15.8%-5.65%
NIKINiki BioSolutions, Inc.$1M———-3.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.